... after treatment were the most useful predictors of progression-free (p = 0.004) or cause-specific survival (p = 0.006) in a multivariate Cox proportional-hazard model including histologic grade, age, performance status and pretreatment hemoglobin. Conclusions: We have found that a low PSA level 2 months...

... survival of 6.3 years compared to 34 who died from intercurrent disease with a median survival of only 2.6 years. The observed survival for the whole group was similar to the expected survival for an age-matched population in Scotland. This was despite the fact that the nodal status and the capsular...

... on the whole pelvis at 3-4 weeks interval (66-108 days). Group C patients, not suitable for radical treatment,received only 40-54 Gy photon equivalent (26-70 days). The overall 5-year actuarial survival rate was 30% (SE 8%). As expected, T stage was a statistically significant prognostic factor. The overall...

...E.B. Jakobsen; J.H. Eickhoff; J.P. Andersen; M. Ottesen We retrospectively studied the effect of perioperative blood transfusion in 208 transfused and 50 nontransfused patients operated on during a 12-year period for renal cell cancer. The 5-year renal cell cancer specific survival rate was 0.46...

...J. Aparicio; J. Montalar; E.B. Munárriz; G. Reynés; J. Gómez-Codina; M. Pastor; C. Herranz The records of 23 patients (22 male and 1 female, median age 28 years) with extragonadal germ cell tumors (EGCT) treated between 1974 and 1993 were reviewed retrospectively to investigate long-term survival...

... cancer Radical radiotherapy p53 immunostaining Rb immunostaining Local response Survival Research Paper EurUrol 1995;28:135-142 1605268 S. Jahnsona B. Risbergb M.G. Karlsson b G. Westman0 R. Bergstromd J. Pedersen a Departments of a Urology, b Pathology and c Radiotherapy, Örebro Medical Centre...

.... These patients experienced a better survival than those who had not been exposed in BN foci. An opposite finding of the only author who previously tried to quantify survival in the same region by a similar approach was explained by two main reasons: his failure to control a considerable age difference between...

.... The patient survival rate was comparable to that of T(3)N(o)M(o)-staged cases. Survival rates at 1 and 4 years were, respectively, 96.8 and 40% for V(2) cases, 100 and 100% for V(3), 85.7 and 40% for V(4). It seems, therefore, that in patients with locorégional disease and satisfactory conditions...

...Sophie Dorothea Fosså; Kirsten Sundby Hall; Nils B. Johannessen; Thomas Urnes; Olav Kaalhus The cancer-related 5-year survival was 80% in 79 patients with penile cancer treated at the Norwegian Radium Hospital from 1974 to 1985 (N(0) = 61, N(1-2) = 12, N(3) = 6). Sentinal node biopsy (SLN...

... in the removed bladder at surgery. For these cases, 3-year and 5-year survival rates were 100%. On the other hand, for cases whose destruction of tumor structures was of mild degree or less, 3-year survival rates were 51.9-57.1 %. No serious side effect was observed. This preoperative therapy was thought...

... we used 40 patients, chosen at random, with stage C and stage D cancer of the prostate gland who were treated with stilbestrol and orchiectomy. The survival rate is improved in patients treated with cyproterone acetate and orchiectomy compared to the patients treated with stilbestrol and orchiectomy...

...-based chemotherapy cycles after surgery,if possible, containing cytostatic agents not given during induction chemotherapy. All patients were followed up until death or January 1st, 1995(median observation time in surviving patients: 51 months; range: 9-166 months). Results: Sixteen patients developed...

..., 23X2 Gy; group 2: 34 patients, 5X4 Gy; group 3: 46 patients, 0 Gy). Crude and disease-free survival was 40 and 54%, respectively, in this retrospective study. No survival difference was observed between the different groups. ‘Stage reduction’ in the cystectomy specimen (P<T) was the only significant...

... to histopathological grade, mean nuclear area or SD of nuclear area. The progress in nodal or metastatic stage could be predicted by histopathological grade, mean nuclear area and SD of the nuclear area. Prediction of crude survival, however, was not efficient. When only bladder cancer deaths were included...

...Johannes Flamm In a prospective randomized study the influence of short-term instillation therapy versus long-term instillation therapy after transurethral resection of superficial transitional cell bladder cancer on tumor recurrence,tumor progression and patient survival were evaluated. The data...

...P. Sánchez de la Muela; D. Rosell; L. Agüera; F. De Castro; W. Isa; J.E. Robles; J.J. Zudaire; J.M. Berián Two hundred and seventeen consecutive patients with superficial bladder cancer stages T(a)-T(1) were analyzed for survival and prognostic factors. The overall 5-year survival was 88 ± 5.3...

...G. Citterio; A. Bertuzzi; M. Tresoldi; L. Galli; G. Di Lucca; U. Scaglietti; C. Rugarli Objective: Metastatic renal cell cancer (RCC) portends a bad prognosis, but survival is quite different among different patients. The objective of this study was to determine prognostic factors for survival...

...(TCCs) and to determine their relationships to tumour grade, stage and survival. Materials and Methods: The expression of p53, c-jun and PCNA was studied using immunohistochemistry in formalin-fixed, paraffin-embedded tissues in a series of 110 TCCs. Results: 58% of our cases were positive for p53...

..., whereas histological grade had no significant predictive value. The clinical stage (T) predicted crude survival (p = 0.0005). Results show that FCM gives prognostic information in prostatic adenocarcinoma beyond that of histological grading. 11 8 2017 1991 Copyright / Drug Dosage...

... prostatectomy. Compared with younger patients, elderly patients had a higher pathologic stage (71 versus 45% stage pT3 or greater, p < 0.001) and higher-grade lesions (49 versus 21 %, p < 0.001). Survival was significantly worse compared with age-matched controls for younger patients with high-stage...